Tel:
Fax:
Email:
Creative Biolabs
Product

NeuroMab™ Anti-EPHA2 BBB Shuttle Antibody,Clone NR899P

[CAT#: NRZP-1022-ZP3874]

Host Species:
Mouse
Species Reactivity:
Human
Applications:
Inhib; In Vitro; Agonist

Datasheet MSDS Request COA

Certificate of Analysis Lookup
To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.
Lot Number

Inquiry

SPECIFIC INQUIRY

inquiry
Size:
Conjugation:
Endotoxin:
Purity:
Engineering:
Product Overview

Description

Brain uptake of therapeutic antibodies is severely limited by their size. To achieve enhanced BBB crossing, Creative Biolabs developed a BBB shuttle antibody platform by utilizing the endogenous macromolecule transportation pathway, known as receptor-mediated transcytosis (RMT). The engineered antibody-based carrier is believed to significantly to increase the macromolecule brain entry to combat CNS diseases.
Notes: The BBB antibody is made-to order and available in a customized format. Please don't hesitate contact us for more details.

Species Reactivity

Human

Clonality

Monoclonal

Host Species

Mouse

Clone Number

NR899P

Applications

Inhib; In Vitro; Agonist

Relevant Diseases

Glioblastoma Multiforme
Product Properties

Storage

Store at -20°C. Do not aliquot the antibody.

Research Use Only

For research use only
Target

Target

EPHA2

Official Name

EPHA2

Full Name

EPH receptor A2 (ephrin type-A receptor 2)

Alternative Names

EPHA2; Epha2; AW545284; Eck; Myk2; Sek-2; Sek2; ARCC2; CTPA; CTPP1; CTRCT6; EPH receptor A2; ECK
Product Pictures
FuncS

Figure 1 ITC curve of 135H11 against EphA2-LBD (Kd = 150 nM)

FuncS

Figure 2 Comparison of DELFIA shift dose response curves of 123B9, 135G3 and 135H11

FuncS

Figure 3 135H12 alters EphA2 cellular localization.

FuncS

Figure 4 135H12 and 135H11 inhibit cell invasion. 7 x 105 BxPC3 cells were seeded into each well of a 96-well plate and processed the next day. Plates were processed once and imaged every 6 hours for 6 days.

FuncS

Figure 5 135H12 and 135H11 inhibit cell migration. BxPC3 cells were plated and processed similarly to the invasion assay. Plates were imaged every 6 h for 36 h. (5C) Time-dependent inhibition of pancreatic cancer cell invasion and migration when treated with 135H11 (monomer) and 135H12 (dimer).

FuncS

Figure 6 Time-dependent inhibition of pancreatic cancer cell invasion and migration when treated with 135H11 (monomer) and 135H12 (dimer). Both agonists inhibited cell invasion, while 135H12 showed a more pronounced inhibition of cell migration than its monomeric counterpart 135H11. Invasion assay n = 5, migration assay n = 10. Error bars are SEM. ****, p = 0.0001; ***, P = 0.0002; **, P = 0.003.

FuncS

Figure 7 Isothermal titration calorimetry (ITC) curves of binding between sterically restricted peptides and EphA2-LBD.

FuncS

Figure 8 Representative images of each treatment at time 0, 12, and 24 hours.

FuncS

Figure 9 Summary of migration of BxPC3 cells over time when treated with 135H11 (monomer) and 135H12 (dimer). Error bars are SEM. ****, p=0.0001; *, P=0.01, n=4.

FuncS

Figure 10A. 1D lH-aliph. 2D [15N, ¾] ultrafast HSQC spectra of 15N-EphA2-LBD NMR spectra were measured in the absence and presence of various concentrations of 135H11. Spectra were collected on a 700 MHz Bruker NMR spectrometer equipped with a TCI cryoprobe. The spectrum of the complex after titration exhibits a slow exchange in the NMR time scale.

FuncS

Figure 10B. 1D lH-aliph. 2D [15N, ¾] ultrafast HSQC spectra of 15N-EphA2-LBD NMR spectra were measured in the absence and presence of various concentrations of 135H11. Spectra were collected on a 700 MHz Bruker NMR spectrometer equipped with a TCI cryoprobe. The spectrum of the complex after titration exhibits a slow exchange in the NMR time scale.

Publications

Publications (0)

gift-card

Related Products
For Research Use Only. Not For Clinical Use.
Send Inquiry Send Inquiry
Inquiry Basket
compare

Send inquiry